7b-hydroxyhyoscyamine

Racanisodamine (7β-Hydroxyhyoscyamine) is an anticholinergic and α1-adrenergic receptor antagonist used in the treatment of acute circulatory shock.

Anisodamine Hydrobromide (6-Hydroxyhyoscyamine) is an anticholinergic and α1-adrenergic receptor antagonist used in the treatment of acute circulatory shock.

Anisodamine (6-beta-Hydroxyhyoscyamine) is an antagonist of muscarinic and nicotinic cholinoceptor with similar affinities at the muscarinic receptor as scopolamine and atropine. Anisodamine improve the microcirculation in states of shock and can be used in studies about organophosphate poisoning.

Racanisodamine (Standard) is the standard substance of Racanisodamine, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Racanisodamine (7β-Hydroxyhyoscyamine) is an anticholinergic and α1-adrenergic receptor antagonist used in the treatment of acute circulatory shock.

Anisodamine hydrochloride, an anticholinergic and α1 adrenergic receptor antagonist, is used for enhancing blood flow in circulatory disorders like septic shock. It exhibits a range of pharmacological effects similar to Atropine and Scopolamine, including the inhibition of salivation, gastrointestinal and sweat secretion, gastrointestinal motility, respiratory secretion, and urinary bladder contraction in vivo [1].

Anisodamine Hydrobromide (Standard) is a reference standard for research and analysis in studies involving Anisodamine Hydrobromide. Anisodamine Hydrobromide (6-Hydroxyhyoscyamine) is an anticholinergic and α1-adrenergic receptor antagonist used in the treatment of acute circulatory shock.